Top 3 preferred therapeutic treatments for breast cancer

A recent study by Global Market Insights speculates that the breast cancer therapeutics market will record a revenue of $42.6 billion by 2028 end.

Breast cancer is the most prevalent cancer in women across the world and a leading cause of death in many underdeveloped nations. In 2020, around 2.3 million women were diagnosed with breast cancer and nearly 685,000 women died worldwide. The rising number of breast cancer cases and the high mortality rate linked with it will drive the expansion of breast cancer therapeutics market.

Over the years, the increase in the cases of breast cancer has paved way for a plethora of technological innovations and research to find ways to treat cancer. Breast cancers are widely detected by effective screening tests along with MRIs and ultrasounds. Technological advances and ongoing studies are spurring the need for improvements in early detection and screening, which will fuel the breast cancer therapeutics market growth in the upcoming years.